Semarang, Indonesia, Apr 3, 2023 - (ACN Newswire via SEAPRWire.com) - The Governor of Central Java, Indonesia, Ganjar Pranowo, established SMK Negeri Jawa Tengah (SMKN Jateng), a free school for underprivileged students with the concept of a boarding school.Governor of Central Java Ganjar Pranowo initiated a free school for underprivileged studentsInaugurated on June 2, 2014, the school is currently located in three places, namely Semarang City, Purbalingga Regency, and Pati Regency.The presence of SMKN Jateng aims to reduce poverty rates in Central Java through education. All education expenses are borne by the Central Java Provincial Government's regional revenues and expensitures budget (APBD) along with other stakeholders' financial contribution. All student needs such as boarding, food, uniforms, work clothes, stationery, and other necessities are also provided by the Central Java Provincial Government.The main campus of SMKN Jateng is located in Semarang City and covers an area of 3.5 hectares. The school currently accommodates 365 students, consisting of 281 male and 75 female students who are currently in grades one, two, and three.According to the Head of SMKN Jawa Tengah ...

Award recognizes Avantor's outstanding efforts to expand the market reach for life-altering innovative cell and gene therapiesPune, INDIA, April 3, 2023 - (ACN Newswire via SEAPRWire.com) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, has been honored with the Best Bioprocessing Supplier Award for Cell and Gene Therapy at the Biopharma Excellence Awards (BEA) India Edition 2023, organized by IMAPAC in Pune, India. Ganesh Bade – Head of Biopharma India Middle East & Africa (IMEA), Avantor (right) receiving the accolade at the Awards ceremony.The award recognizes Avantor's outstanding efforts to support the expansion of life-altering innovative cell and gene therapies to treat complex disease. Avantor is focused on making valuable contributions to cell and gene therapy production and offers expertise, technology capabilities and commitment to providing solutions. Recently, Avantor was also accorded the Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards (ABEA) 2023 held in Singapore....

HONG KONG, Apr 3, 2023 - (ACN Newswire via SEAPRWire.com) - HG Semiconductor Limited ("HG Semiconductor", together with its subsidiaries, "the Group"; stock code: 6908.HK) announced its audited consolidated results for the year ended 31 December 2022 (the "Year"). HG Semiconductor actively developed its new third-generation semiconductor business during the Year, by further accelerating the pace of research and development ("R&D") and application of gallium nitride ("GaN") technology and achieving several important milestones. During the Year, since the third-generation semiconductor business was still in investment and R&D stage, the Group's revenue was mainly contributed from the LED bead business. The recurring COVID-19 pandemic ("COVID-19" or "Pandemic") had severe negative impact on China's economy. The temporary closure of factories due to lockdown measures among cities had halted the industrial chain of the Group's LED bead business for certain period of time and impacted its production capacity accordingly. Revenue for the Year was approximately RMB87.5 million (2021: approximately RMB126.1 million), while gross profit decreased to RMB16.4 million (2021: approximate...

HONG KONG, Apr 3, 2023 - (ACN Newswire via SEAPRWire.com) - Blockpass is proud to announce that, through consulting and advisory firm Charmwood Risk Management, Blockpass UK is now certified to ISO 27001 by The British Assessment Bureau, a UKAS Accredited Organisation. The award of this certificate (meeting the requirements of BS EN ISO/IEC 27001:2017) confirms Blockpass' ability to provide KYC and AML tools for cryptocurrencies, Defi and other regulated industries globally, demonstrating the suitability of Blockpass for companies seeking regulatory solutions in any jurisdiction. The certificate is available to view here: https://cvs.babcert.com/babcert.asp?c=241611&v=k34q1g2c2qCharmwood Risk Management is a consulting and advisory firm with a global team specializing in supporting businesses with; implementation, internal auditing, staff training and maintenance of a broad range of ISO Management Systems Certifications such as ISO 27001, ISO 27701, ISO 9001, ISO14001, ISO 45001, and many more including technical specifications such as Tisax and PAS 2060 (Carbon Neutrality) and bespoke supply chain audits. Charmwood Risk Management are also approved providers of technical consu...

HONG KONG, Apr 3, 2023 - (亚太商讯 via SEAPRWire.com) - 宏光半导体有限公司（「宏光半导体」，连同其附属公司统称「集团」；股份代号：6908.HK）宣布其截至2022年12月31日止年度（「年内」）之经审核全年业绩。年内，宏光半导体积极发展第三代半导体新业务，进一步加快氮化镓（「GaN」）的技术研发和应用步伐，并实现多个重要里程碑。本年度，由于第三代半导体业务仍处于投放及研发阶段，集团的收益贡献主要来自LED灯珠业务。2019冠状病毒病（「新冠肺炎」或「疫情」）持续反复对中国经济造成严重负面影响；因各地实施封城措施导致工厂临时关闭，使集团LED灯珠业务产业链有部分时间受停顿，产能受到波及，年内收益约为人民币87.5百万元（2021年：约人民币126.1百万元）；毛利亦因而降至人民币16.4百万元（2021年：约人民币25.5百万元）。由于集团并无录得收购无形资产所得亏损等非现金流项目，纵然用于推展及研发第三代半导体业务之开支有所增加，公司拥有人应占之年内亏损大幅收窄至人民币约101.3百万元（2021年：约人民币446.8百万元）。集团管理层表示，年内全球经济复苏受多重下行风险拖累，世界经济呈现动荡态势。纵然如此，全球对半导体的需求量依然巨大。面对国际大环境挑战，集团于年内积极发展GaN新业务，朝着成为以半导体设计与制造为核心，集研发、制造、包装、封测及销售为一体的全产业链半导体整合设备生产模式（「IDM」）企业之目标迈进。业务回顾年内，LED灯珠的收益约为人民币87.2百万元（2021年：约人民币126.1百万元）。收益下降主要由于新冠肺炎疫情反复爆发及出现变异毒株严重损害中国经济，令中国对高端LED产品的需求大幅减少，导致年内LED灯珠平均售价下降。然而，凭借集团的科学家团队的雄厚科研实力以及在研发和生产方面投入的辛勤努力，集团的第三代半导体GaN业务中之外延片及快充产品已于年内开始为集团录得收入贡献。GaN外延片研发及生产实现突破性进展 全力开拓第三代半导体产业链年内，集团在GaN第三代半导体方面的研发、制造及落地得以实现，并快速切入外延片生产。集团已在其位于中国江苏省徐州经济技术开发区的半导体工厂内安装两条用作生产包括GaN相关产品的生产线，同时从欧洲和日本引入的核心机器已运抵厂房，并已准备就绪制造迎合市场需要的芯片。凭借本集团科学家团队的努力以及雄厚的研发实力，集团亦于年内实现重大突破，成功于10月开始生产自家6英吋GaN功率器件外延片，远早于预期时间表成功制造外延片，此乃集团迈向第三代半导体GaN供货商转型的重要成果，为量产GaN芯片铺路。此外，集团于本年度获得九个实用新型及外观专利，包括氮化镓基逆变器及电源组件等，另有多个发明专利正在受理审批中。集团之全资附属公司徐州金沙江半导体有限公司亦于年内与G...

JAKARTA, Apr 1, 2023 - (ACN Newswire via SEAPRWire.com) - Indonesia's Ministry of Communications and Informatics (MCI) is preparing digital infrastructure to support the successful ASEAN Chairmanship 2023. Acting Director-General of Posts and Informatics Operations of the Ministry of Communications and Informatics, Ismail, stated that his ministry is continuously monitoring the telecommunications network to maintain its quality.Indonesian MCI Ensures Telecommunication Access for Successful ASEAN Chairmanship 2023"One of MCI's tasks is to provide telecommunications networks and internet access to ensure the smooth running of ASEAN Chairmanship 2023," he emphasized in Jakarta on Friday, March 31, 2023.Ismail also stated that specifically for the ASEAN Summit slated to be held in May 2023 in Labuan Bajo, East Nusa Tenggara, MCI has ensured adequate network infrastructure. There are 3,773.73 km of fiber optic network and 2,055 ODP points in the area. In addition, there are 1,635 4G BTS and 3 5G BTS.Regarding the quality of the network, Ismail stated that Labuan Bajo, which had previously hosted the G20 event, has been served by 4G and 5G telecommunication networks. In fact, fixed broad...

AMSTERDAM, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - To prove how easy it is for anyone to launch a scam site, the Global Anti Scam Alliance and ScamAdviser launched 'ScamAdviser Coin' in the lead-up to April Fool's Day 2023. The goal of this campaign was to highlight the importance of forming better policies to combat scammers.Investment Options ScamAdviser CoinLast year, nearly 300 million consumers lost more than $55 billion, according to the Global State of Scams 2022 report. Especially, investment scams continued to rise, caused by digitalization, high inflation, and the increasing cost of living.Within a matter of days, a website was set up that promised investors 100% returns in 14 days. Setting up the site was just $250, including purchasing a website template, registering the domain name 'scamadviser.club' and purchasing website hosting.UK's Companies House lacks a Due Diligence processTo create a sense of trust, a fictitious company named 'ScamAdviser Coin Limited' was registered in the UK's Companies House Registry, using as Directors names the notorious fraudsters Charles Ponzi and Bernard Madoff for just $15.This is possible as the Companies House itself states...

HONG KONG, Mar 31, 2023 - (亚太商讯 via SEAPRWire.com) - 中国领先的创新研发驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）公布截至2022年12月31日止12个月之经审核财务业绩。重点成果肿瘤创新药-- 福可维（盐酸安罗替尼胶囊）目前已获批五个适应症：三线非小细胞肺癌、三线小细胞肺癌、软组织肉瘤、甲状腺髓样癌和分化型甲状腺癌。-- 安罗替尼联合TQB2450（抗PD-L1）用于治疗一线小细胞肺癌的III期临床试验已完成期中分析，达到预设终点，并已向国家药监局药品审评中心（「CDE」）递交上市申请。-- 安罗替尼另有12个新适应症的临床研究已经进入III期，包含安罗替尼与派安普利单抗联用、安罗替尼与TQB2450（抗PD-L1）联用，安罗替尼与化疗联用等多种治疗方案，预计将在未来一到两年内逐步递交上市申请。-- 安尼可（派安普利单抗）注射液于 2023 年 1 月获批联合化疗用于一线局部晚期或转移性鳞状非小细胞肺癌的治疗。至今，派安普利单抗已获批两个适应症：三线经典型霍奇金淋巴瘤和一线鳞状非小细胞肺癌。另外，派安普利单抗有一个适应症（三线鼻咽癌）正在上市审评过程当中。-- F-627（艾贝格司亭α，长效G-CSF）目前正处于上市申请阶段。F-627是目前市场上唯一一个与短效和长效G-CSF同时进行过大样本量头对头研究的G-CSF药物，在中美两地完成了临床III期研究，并分别在中美递交了上市申请，预计2023年将在中国获批。依托其强大的肿瘤销售团队，集团有信心将该产品成功推广并快速抢占市场。肝病创新药-- 拉尼兰诺（泛PPAR激动剂）是一种口服小分子药物，目前该产品正在全球进行III期临床试验，是中国第一个进入临床III期的NASH口服药物，有望填补中国NASH市场空白。呼吸创新药-- 恩司特韦（3CL 蛋白酶抑制剂）是一款新型口服 COVID-19 治疗药物，目前已向国家药监局 CDE 提交上市申请，或将成为 COVID-19 治疗领域的优质口服药物。外科/镇痛创新药-- 抗菌肽产品PL-5是全新设计的首款非抗生素类抗菌药物。该产品目前在国内已完成针对治疗继发性创面感染的III期临床研究，预计将于年内申报上市，有望成为国内首个上市的抗菌肽产品。仿制药-- 截至本公告日，集团年收入人民币 5 亿以上的仿制药产品（剔除独家产品）均已纳入集采范围，尚未纳入集采范围的仿制药存量业务已经见底，集采风险基本出清。年内，集团录得收入约287.8亿元（人民币，下同），按年增长约7.1%。归属于母公司持有者应占盈利约25.4亿元。基于归属于母公司持有者应占盈利计算之每股盈利约13.66分，按年减少约82.4%。扣除应占联营公司及一家合营公司盈利及亏损（扣除相关税项...

HONG KONG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2022.Development HighlightsOncology Innovative Drugs-- Focus V (Anlotinib Hydrochloride Capsules) has been approved for five indications: third-line non-small cell lung cancer, third-line small cell lung cancer, soft tissue sarcoma, medullary thyroid cancer and differentiated thyroid cancer. -- The Phase III clinical trials of Anlotinib in combination with TQB2450 (PD-L1) for the treatment of first-line small cell lung cancer has completed interim analysis and met the pre-specified endpoint.-- In addition, 12 new indications for Anlotinib have also entered Phase III clinical trials, including the combination of Anlotinib with Penpulimab monoclonal antibody, Anlotinib with TQB2450 (PD-L1), Anlotinib with chemotherapy, and other treatment options, for which marketing applications are expected to be submitted progressively in the next one to two years.-- Annike (...

SINGAPORE, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - ACROMETA Group Limited, an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biotechnology, pharmaceutical, research and academia sectors, has entered into a Sales and Purchase Agreement ("the Agreement") for an additional 40% of the outstanding shares of Life Sciences Incubator Pte Ltd ("LSI") for a total consideration of S$1.6 million payable in tranches, based on the realisation of agreed milestones in its immediate expansion plan. Upon completion of the purchase, the Group will control 70% of LSI, up from the current 30%. The Agreement updates and follows from the Letter of Intent ("LOI") announced to SGXNet on 20 February 2023 for the proposed acquisition of an additional 40% stake in LSI.A site visit to Brisbane and the due diligence carried out by ACROMETA Management have shortlisted the location of the proposed co-working laboratory in Australia as it found it suitable. Mr Levin Lee Keng Weng, ACROMETA Chairman, said, "Brisbane is a booming hub for the Life Sciences sector in Australia. According to Global Australia[1], a government-industry ...